Why Dose Tracking Matters
At-home ketamine troche therapy requires a level of patient self-monitoring that differs from taking a daily antidepressant. Because sessions occur periodically, effects vary between sessions, and dose adjustments are made based on response data, systematic tracking is not a nice-to-have — it's a core part of responsible treatment.
Without good tracking, dose decisions are made on incomplete information, patterns are missed, and early warning signs of problems can go unnoticed. With tracking, you and your provider can make informed, evidence-based decisions about your treatment. This data is especially valuable during titration when dose adjustments are being made.
What to Track: The Core Data Points
Session-Level Data
For every session, record:
Date and time: When the session began.
Dose: The exact dose in milligrams (e.g., "200 mg ketamine HCl troche, sublingual").
Lot number / pharmacy batch (optional but useful): If you ever suspect potency variation between batches, having lot numbers recorded makes it possible to identify which batch was involved.
Administration route: Sublingual or buccal.
Onset time: How long from placement to first noticeable effect. Record in minutes.
Peak intensity estimate: On a scale of 1 to 10, how intense were the effects at their peak?
Session duration: Total time from troche placement to when effects had substantially resolved.
Key session content: Brief notes on emotional themes, imagery, or realizations that emerged. This doesn't need to be exhaustive — even two or three words per theme suffices.
Adverse events: Nausea, elevated heart rate, anxiety, confusion, any physical symptoms. Our side effects quick guide covers what is normal and what warrants a call to your provider. Include approximate severity (mild, moderate, severe) and whether they resolved during the session.
Post-Session Data (Days Following)
Day 1 after session: Rate overall mood, anxiety level, and pain level (if applicable) on a 0 to 10 scale. Note any sleep disturbances, cognitive fog, or notable changes in how you feel.
Days 2 to 7: Continue daily ratings. The trajectory of mood from session to session is one of the most informative data points your provider uses to assess treatment adequacy.
Functional markers: Track specific functional improvements or regressions. For depression: "Was I able to do the laundry?" "Did I initiate a social activity?" For anxiety: "Did I avoid any situations this week?" For pain: "How many hours was I able to be on my feet?"
Tools for Tracking
Paper Journal
A dedicated notebook used exclusively for ketamine session tracking is simple and reliable. Some patients create a one-page template that they photocopy and fill out for each session. Paper records cannot be lost to a crashed app or technical failure and do not require any learning curve.
Template structure:
SESSION DATE: ___________
DOSE (mg): ___________
ROUTE: Sublingual / Buccal
TIME PLACED: _____ FIRST EFFECTS: _____ PEAK: _____ RESOLVED: _____
PEAK INTENSITY (1-10): ___
ADVERSE EFFECTS: ___________
SESSION THEMES/NOTES: ___________
POST-SESSION TRACKING (circle + notes):
Day 1 Mood: 1 2 3 4 5 6 7 8 9 10 Notes: ___
Day 2 Mood: 1 2 3 4 5 6 7 8 9 10 Notes: ___
Day 3 Mood: 1 2 3 4 5 6 7 8 9 10 Notes: ___
Day 4 Mood: 1 2 3 4 5 6 7 8 9 10 Notes: ___
Day 5 Mood: 1 2 3 4 5 6 7 8 9 10 Notes: ___
Digital Spreadsheet
Google Sheets or Excel allows easy data organization and simple graphing. A spreadsheet lets you visualize mood trends over multiple sessions, which makes pattern recognition much easier. Share it with your provider through a secure message or printout before appointments.
Mood Tracking Apps
General mental health apps like Daylio, Bearable, or Moodfit offer mood tracking with symptom logging and can serve double duty as general tracking tools. Some patients use these for daily monitoring between sessions. Note that none are specifically designed for ketamine therapy, so you may need to customize symptom categories.
Provider-Supplied Tools
Some ketamine telemedicine platforms provide patient portals with built-in tracking tools, symptom scales (PHQ-9 for depression, GAD-7 for anxiety), and secure messaging to share data between visits. If your provider offers these, use them — the data flows directly into your clinical record.
Standardized Symptom Scales
Incorporating validated clinical rating scales into your tracking makes your data more interpretable by your provider. The most common:
PHQ-9 (Patient Health Questionnaire-9)
A 9-item self-report scale for depression severity. Score 0 to 27, with higher scores indicating more severe symptoms. Complete at baseline and repeat every 1 to 2 weeks. A drop of 5 or more points generally indicates a clinically meaningful response.
GAD-7 (Generalized Anxiety Disorder-7)
A 7-item scale for anxiety severity. Score 0 to 21. Complete alongside the PHQ-9 if anxiety is a treatment target.
PCL-5 (PTSD Checklist for DSM-5)
A 20-item PTSD symptom scale. Relevant for patients using ketamine for PTSD. Complete monthly to track trauma symptom trends.
Pain Numerical Rating Scale (NRS)
For chronic pain patients: rate pain intensity from 0 (no pain) to 10 (worst imaginable pain) at consistent times of day, ideally morning and evening. Also track pain interference with function using the Brief Pain Inventory if your provider recommends it.
Tracking Ketamine Use for Safety
Beyond therapeutic monitoring, tracking serves a controlled substance accountability function. Your records document:
- Exact dates and doses of use
- Total troches consumed versus prescribed
- That use is occurring within the parameters of your prescription
If you ever need to demonstrate appropriate use of your prescription — to your prescriber, insurer, or in an unexpected regulatory encounter — having organized records is protective.
Warning Signs to Monitor
Your tracking should flag:
- Increasing frequency: Using troches more often than prescribed is a warning sign worth discussing with your provider, not explaining away.
- Dose escalation beyond prescription: Using more than one troche per session without prescriber guidance.
- Use outside session framework: Taking troches impulsively or to manage acute emotional distress rather than within a planned therapeutic structure.
- Decreasing intervals between sessions: A gradual shortening of the time between sessions may indicate psychological dependence dynamics developing.
If you notice any of these patterns in your tracking, discuss them honestly with your prescriber. This is a safety issue, not a moral one.
Sharing Data With Your Provider
Your tracking data is only useful if it informs clinical decisions. Bring your tracking records to every provider appointment:
- Print or photograph your session log
- Prepare a brief verbal summary of trends: "Since my last visit, I've had three sessions at 200 mg. The first two showed good mood improvement for 3 to 4 days afterward. The third session was less effective."
- Highlight any adverse effects, pattern changes, or concerns
- Share your standardized scale scores so they can be compared to baseline
Providers who have this information can make better decisions than those relying on a patient's general impression during a 15-minute appointment.
Key Takeaways
- Track every ketamine session: date, dose, route, onset time, intensity, duration, session themes, and adverse effects.
- Rate mood, anxiety, pain, and function daily for 5 to 7 days after each session.
- Use a paper journal, spreadsheet, or app — whichever you'll actually use consistently.
- Incorporate validated scales (PHQ-9, GAD-7, PCL-5) for standardized outcome measurement.
- Share tracking data with your provider before every appointment.
- Use tracking to monitor for patterns that might indicate problematic use, and discuss any concerns honestly with your prescriber.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
- WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches
Share